ID   LIMK1_HUMAN             Reviewed;         647 AA.
AC   P53667; O15283; Q15820; Q15821; Q75MU3; Q9Y5Q1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   02-NOV-2010, entry version 117.
DE   RecName: Full=LIM domain kinase 1;
DE            Short=LIMK-1;
DE            EC=2.7.11.1;
GN   Name=LIMK1; Synonyms=LIMK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=94239736; PubMed=8183554;
RA   Mizuno K., Okano I., Ohashi K., Nunoue K., Kuma K., Miyata T.,
RA   Nakamura T.;
RT   "Identification of a human cDNA encoding a novel protein kinase with
RT   two repeats of the LIM/double zinc finger motif.";
RL   Oncogene 9:1605-1612(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   TYR-580.
RC   TISSUE=Hippocampus, and Placenta;
RX   MEDLINE=96291399; PubMed=8689688; DOI=10.1016/S0092-8674(00)80077-X;
RA   Frangiskakis J.M., Ewart A.K., Morris C.A., Mervis C.B., Bertrand J.,
RA   Robinson B.F., Klein B.P., Ensing G.J., Everett L.A., Green E.D.,
RA   Proeschel C., Gutowski N.J., Noble M., Atkinson D.L., Odelberg S.J.,
RA   Keating M.T.;
RT   "LIM-kinase1 hemizygosity implicated in impaired visuospatial
RT   constructive cognition.";
RL   Cell 86:59-69(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT TYR-580, AND GENE DELETION
RP   IN WILLIAMS-BEUREN SYNDROME.
RX   MEDLINE=96411691; PubMed=8812460; DOI=10.1006/geno.1996.0469;
RA   Osborne L.R., Martindale D.W., Scherer S.W., Shi X.-M., Huizenga J.,
RA   Heng H.H.Q., Costa T., Pober B., Lew L., Brinkman J., Rommens J.,
RA   Koop B.F., Tsui L.-C.;
RT   "Identification of genes from a 500-kb region at 7q11.23 that is
RT   commonly deleted in Williams syndrome patients.";
RL   Genomics 36:328-336(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SELF-ASSOCIATION,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-84; 177-GLY-LEU-178;
RP   ASP-460; 496-ARG--ARG-506; 503-ARG--GLY-505 AND THR-508.
RC   TISSUE=Epidermal carcinoma;
RX   MEDLINE=99214220; PubMed=10196227; DOI=10.1074/jbc.274.16.11352;
RA   Edwards D.C., Gill G.N.;
RT   "Structural features of LIM kinase that control effects on the actin
RT   cytoskeleton.";
RL   J. Biol. Chem. 274:11352-11361(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH ROCK1.
RX   PubMed=10436159; DOI=10.1126/science.285.5429.895;
RA   Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A.,
RA   Obinata T., Ohashi K., Mizuno K., Narumiya S.;
RT   "Signaling from Rho to the actin cytoskeleton through protein kinases
RT   ROCK and LIM-kinase.";
RL   Science 285:895-898(1999).
RN   [7]
RP   PHOSPHORYLATION AT THR-508, MUTAGENESIS OF THR-508, AND INTERACTION
RP   WITH ROCK1.
RX   PubMed=10652353; DOI=10.1074/jbc.275.5.3577;
RA   Ohashi K., Nagata K., Maekawa M., Ishizaki T., Narumiya S., Mizuno K.;
RT   "Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation
RT   at threonine 508 within the activation loop.";
RL   J. Biol. Chem. 275:3577-3582(2000).
RN   [8]
RP   FUNCTION.
RX   MEDLINE=21822082; PubMed=11832213; DOI=10.1016/S0092-8674(01)00638-9;
RA   Niwa R., Nagata-Ohashi K., Takeichi M., Mizuno K., Uemura T.;
RT   "Control of actin reorganization by Slingshot, a family of
RT   phosphatases that dephosphorylate ADF/cofilin.";
RL   Cell 108:233-246(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=12807904; DOI=10.1074/jbc.M305802200;
RA   Kaji N., Ohashi K., Shuin M., Niwa R., Uemura T., Mizuno K.;
RT   "Cell cycle-associated changes in Slingshot phosphatase activity and
RT   roles in cytokinesis in animal cells.";
RL   J. Biol. Chem. 278:33450-33455(2003).
RN   [10]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [11]
RP   FUNCTION, INTERACTION WITH SSH1, PHOSPHORYLATION AT THR-508, AND
RP   DEPHOSPHORYLATION.
RX   PubMed=15660133; DOI=10.1038/sj.emboj.7600543;
RA   Soosairajah J., Maiti S., Wiggan O., Sarmiere P., Moussi N.,
RA   Sarcevic B., Sampath R., Bamburg J.R., Bernard O.;
RT   "Interplay between components of a novel LIM kinase-slingshot
RT   phosphatase complex regulates cofilin.";
RL   EMBO J. 24:473-486(2005).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16230460; DOI=10.1083/jcb.200504029;
RA   Nishita M., Tomizawa C., Yamamoto M., Horita Y., Ohashi K., Mizuno K.;
RT   "Spatial and temporal regulation of cofilin activity by LIM kinase and
RT   Slingshot is critical for directional cell migration.";
RL   J. Cell Biol. 171:349-359(2005).
RN   [13]
RP   INTERACTION WITH TPPP.
RX   PubMed=18028908; DOI=10.1016/j.yexcr.2007.08.012;
RA   Acevedo K., Li R., Soo P., Suryadinata R., Sarcevic B., Valova V.A.,
RA   Graham M.E., Robinson P.J., Bernard O.;
RT   "The phosphorylation of p25/TPPP by LIM kinase 1 inhibits its ability
RT   to assemble microtubules.";
RL   Exp. Cell Res. 313:4091-4106(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-310, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210; THR-229; SER-298;
RP   SER-310 AND SER-337, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-307 AND
RP   SER-310, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-310, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210; THR-229; THR-261;
RP   THR-270; SER-296; SER-298; SER-302; SER-307; SER-310 AND SER-313, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-190; ASN-247 AND GLN-422.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase which regulates actin filament dynamics.
CC       Phosphorylates and inactivates the actin binding/depolymerizing
CC       factor cofilin, thereby stabilizing the actin cytoskeleton.
CC       Stimulates axonal outgrowth and may be involved in brain
CC       development. Isoform 3 has a dominant negative effect on actin
CC       cytoskeletal changes.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Self-associates. The LIM domain interacts with the
CC       cytoplasmic domain of NRG1. Binds ROCK1. Interacts with SSH1.
CC       Interacts with NISCH (By similarity). Interacts with RLIM and RNF6
CC       (By similarity). Interacts with TPPP.
CC   -!- INTERACTION:
CC       O95835:LATS1; NbExp=3; IntAct=EBI-444403, EBI-444209;
CC       Q13177:PAK2; NbExp=2; IntAct=EBI-444403, EBI-1045887;
CC       P63104:YWHAZ; NbExp=1; IntAct=EBI-444403, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell projection, growth cone (By
CC       similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P53667-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P53667-2; Sequence=VSP_003125;
CC       Name=3;
CC         IsoId=P53667-3; Sequence=VSP_003126, VSP_003127;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC   -!- TISSUE SPECIFICITY: Highest expression in both adult and fetal
CC       nervous system. Detected ubiquitously throughout the different
CC       regions of adult brain, with highest levels in the cerebral
CC       cortex. Expressed to a lesser extent in heart and skeletal muscle.
CC   -!- PTM: Autophosphorylated (By similarity).
CC   -!- PTM: Phosphorylated on serine and/or threonine residues by ROCK1.
CC       May be dephosphorylated and inactivated by SSH1.
CC   -!- PTM: Ubiquitinated. 'Lys-48'-linked polyubiquitination by RNF6
CC       leads to proteasomal degradation through the 26S proteasome,
CC       modulating LIMK1 levels in the growth cone and its effect on
CC       axonal outgrowth. Also polyubiquitinated by RLIM (By similarity).
CC   -!- DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome
CC       (WBS) critical region. WBS results from a hemizygous deletion of
CC       several genes on chromosome 7q11.23, thought to arise as a
CC       consequence of unequal crossing over between highly homologous
CC       low-copy repeat sequences flanking the deleted region.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 2 LIM zinc-binding domains.
CC   -!- SIMILARITY: Contains 1 PDZ (DHR) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26309; BAA05371.1; -; mRNA.
DR   EMBL; U62293; AAB17545.1; -; Genomic_DNA.
DR   EMBL; U62293; AAB17546.1; -; Genomic_DNA.
DR   EMBL; U63721; AAC13885.1; -; Genomic_DNA.
DR   EMBL; U63721; AAC13886.1; -; Genomic_DNA.
DR   EMBL; AF134379; AAD25742.1; -; mRNA.
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005057; AAS07438.1; -; Genomic_DNA.
DR   IPI; IPI00216433; -.
DR   IPI; IPI00216434; -.
DR   IPI; IPI00291702; -.
DR   PIR; JP0078; JP0078.
DR   RefSeq; NP_002305.1; -.
DR   UniGene; Hs.647035; -.
DR   ProteinModelPortal; P53667; -.
DR   SMR; P53667; 20-140, 154-277, 335-607, 339-640.
DR   IntAct; P53667; 10.
DR   MINT; MINT-2833166; -.
DR   STRING; P53667; -.
DR   PhosphoSite; P53667; -.
DR   PRIDE; P53667; -.
DR   Ensembl; ENST00000336180; ENSP00000336740; ENSG00000106683.
DR   GeneID; 3984; -.
DR   KEGG; hsa:3984; -.
DR   UCSC; uc003uaa.1; human.
DR   CTD; 3984; -.
DR   GeneCards; GC07P073497; -.
DR   H-InvDB; HIX0201131; -.
DR   HGNC; HGNC:6613; LIMK1.
DR   HPA; HPA028064; -.
DR   HPA; HPA028516; -.
DR   MIM; 601329; gene.
DR   Orphanet; 904; Williams syndrome.
DR   PharmGKB; PA30386; -.
DR   eggNOG; prNOG16629; -.
DR   HOVERGEN; HBG052328; -.
DR   InParanoid; P53667; -.
DR   PhylomeDB; P53667; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; caspase_pathway; Caspase cascade in apoptosis.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 15626; -.
DR   ArrayExpress; P53667; -.
DR   Bgee; P53667; -.
DR   CleanEx; HS_LIMK1; -.
DR   Genevestigator; P53667; -.
DR   GermOnline; ENSG00000106683; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0051444; P:negative regulation of ubiquitin-protein li...; IDA:BHF-UCL.
DR   GO; GO:0032233; P:positive regulation of actin filament bundl...; IDA:BHF-UCL.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0007266; P:Rho protein signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001478; PDZ/DHR/GLGF.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR001781; Znf_LIM.
DR   Gene3D; G3DSA:2.10.110.10; Znf_LIM; 2.
DR   Pfam; PF00412; LIM; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00132; LIM; 2.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50156; PDZ; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Complete proteome;
KW   Cytoplasm; Kinase; LIM domain; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Repeat; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation; Williams-Beuren syndrome; Zinc.
FT   CHAIN         1    647       LIM domain kinase 1.
FT                                /FTId=PRO_0000075803.
FT   DOMAIN       25     75       LIM zinc-binding 1.
FT   DOMAIN       84    137       LIM zinc-binding 2.
FT   DOMAIN      165    258       PDZ.
FT   DOMAIN      339    604       Protein kinase.
FT   NP_BIND     345    353       ATP (By similarity).
FT   ACT_SITE    460    460       By similarity.
FT   BINDING     368    368       ATP (By similarity).
FT   MOD_RES     210    210       Phosphoserine.
FT   MOD_RES     229    229       Phosphothreonine.
FT   MOD_RES     261    261       Phosphothreonine.
FT   MOD_RES     270    270       Phosphothreonine.
FT   MOD_RES     296    296       Phosphoserine.
FT   MOD_RES     298    298       Phosphoserine.
FT   MOD_RES     302    302       Phosphoserine.
FT   MOD_RES     307    307       Phosphoserine.
FT   MOD_RES     310    310       Phosphoserine.
FT   MOD_RES     313    313       Phosphoserine.
FT   MOD_RES     337    337       Phosphoserine.
FT   MOD_RES     508    508       Phosphothreonine; by ROCK1.
FT   VAR_SEQ       1     14       Missing (in isoform 2).
FT                                /FTId=VSP_003125.
FT   VAR_SEQ     294    305       LRSCSIDRSPGA -> FARTWVALSPSA (in isoform
FT                                3).
FT                                /FTId=VSP_003126.
FT   VAR_SEQ     306    647       Missing (in isoform 3).
FT                                /FTId=VSP_003127.
FT   VARIANT     190    190       G -> A (in dbSNP:rs35827364).
FT                                /FTId=VAR_042246.
FT   VARIANT     247    247       S -> N (in dbSNP:rs55661242).
FT                                /FTId=VAR_042247.
FT   VARIANT     422    422       R -> Q (in dbSNP:rs55679316).
FT                                /FTId=VAR_042248.
FT   VARIANT     580    580       F -> Y (in dbSNP:rs178412).
FT                                /FTId=VAR_050148.
FT   MUTAGEN      84     84       C->S: Enhances actin aggregation.
FT   MUTAGEN     177    178       GL->EA: Enhances actin aggregation.
FT   MUTAGEN     460    460       D->N: Abrogates kinase activity.
FT   MUTAGEN     496    506       Missing: Reduces actin aggregation.
FT   MUTAGEN     503    505       RKK->GAA: Abolishes kinase activity.
FT   MUTAGEN     508    508       T->A: Abolishes activation by ROCK1.
FT   MUTAGEN     508    508       T->EE: Enhances kinase activity.
FT   MUTAGEN     508    508       T->V,E: Reduces kinase activity.
SQ   SEQUENCE   647 AA;  72585 MW;  9838BEFBE7006447 CRC64;
     MRLTLLCCTW REERMGEEGS ELPVCASCGQ RIYDGQYLQA LNADWHADCF RCCDCSASLS
     HQYYEKDGQL FCKKDYWARY GESCHGCSEQ ITKGLVMVAG ELKYHPECFI CLTCGTFIGD
     GDTYTLVEHS KLYCGHCYYQ TVVTPVIEQI LPDSPGSHLP HTVTLVSIPA SSHGKRGLSV
     SIDPPHGPPG CGTEHSHTVR VQGVDPGCMS PDVKNSIHVG DRILEINGTP IRNVPLDEID
     LLIQETSRLL QLTLEHDPHD TLGHGLGPET SPLSSPAYTP SGEAGSSARQ KPVLRSCSID
     RSPGAGSLGS PASQRKDLGR SESLRVVCRP HRIFRPSDLI HGEVLGKGCF GQAIKVTHRE
     TGEVMVMKEL IRFDEETQRT FLKEVKVMRC LEHPNVLKFI GVLYKDKRLN FITEYIKGGT
     LRGIIKSMDS QYPWSQRVSF AKDIASGMAY LHSMNIIHRD LNSHNCLVRE NKNVVVADFG
     LARLMVDEKT QPEGLRSLKK PDRKKRYTVV GNPYWMAPEM INGRSYDEKV DVFSFGIVLC
     EIIGRVNADP DYLPRTMDFG LNVRGFLDRY CPPNCPPSFF PITVRCCDLD PEKRPSFVKL
     EHWLETLRMH LAGHLPLGPQ LEQLDRGFWE TYRRGESGLP AHPEVPD
//
